113 related articles for article (PubMed ID: 31157623)
1. Survival Trends of Patients With Surgically Resected Gastric Cardia Cancer From 1988 to 2015: A Population-based Study in the United States.
Ze-Long Y; Guo-Hui M; Lin Z; Wei-Hong Y; Ke-Cheng Z; Yan-Wen J
Am J Clin Oncol; 2019 Jul; 42(7):581-587. PubMed ID: 31157623
[TBL] [Abstract][Full Text] [Related]
2. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis.
Wang Y; Zhang J; Guo S; Dong Z; Meng X; Zheng G; Yang D; Zheng Z; Zhao Y
Clin Transl Oncol; 2019 Nov; 21(11):1499-1509. PubMed ID: 30903518
[TBL] [Abstract][Full Text] [Related]
3. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
4. Validating the prognostic and discriminating value of the TNM-classification for gastric cancer - a critical appraisal.
Röcken C; Behrens HM
Eur J Cancer; 2015 Mar; 51(5):577-86. PubMed ID: 25682192
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis.
Shridhar R; Dombi GW; Weber J; Hoffe SE; Meredith K; Konski A
Am J Clin Oncol; 2012 Jun; 35(3):216-21. PubMed ID: 21378540
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant Therapy Improves Survival for T2N0 Gastric Cancer Patients with Sub-optimal Lymphadenectomy.
In H; Kantor O; Sharpe SM; Baker MS; Talamonti MS; Posner MC
Ann Surg Oncol; 2016 Jun; 23(6):1956-62. PubMed ID: 26753752
[TBL] [Abstract][Full Text] [Related]
7. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
Li Y; Zhu Z; Ma F; Xue L; Tian Y
Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
[TBL] [Abstract][Full Text] [Related]
8. The role of the cancer center when using lymph node count as a quality measure for gastric cancer surgery.
Morgan JW; Ji L; Friedman G; Senthil M; Dyke C; Lum SS
JAMA Surg; 2015 Jan; 150(1):37-43. PubMed ID: 25426671
[TBL] [Abstract][Full Text] [Related]
9. Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States: A Propensity Score-matched Analysis.
Datta J; McMillan MT; Ecker BL; Karakousis GC; Mamtani R; Plastaras JP; Giantonio BJ; Drebin JA; Dempsey DT; Fraker DL; Roses RE
Ann Surg; 2016 Feb; 263(2):298-305. PubMed ID: 26135687
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of adjuvant chemoradiotherapy after gastrectomy among older patients with gastric adenocarcinoma: a SEER-Medicare study.
Yeh JM; Tramontano AC; Hur C; Schrag D
Gastric Cancer; 2017 Sep; 20(5):811-824. PubMed ID: 28205057
[TBL] [Abstract][Full Text] [Related]
11. Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.
Coburn NG; Swallow CJ; Kiss A; Law C
Cancer; 2006 Nov; 107(9):2143-51. PubMed ID: 17001662
[TBL] [Abstract][Full Text] [Related]
12. Survival Rates for Patients with Resected Gastric Adenocarcinoma Finally have Increased in the United States.
Arsoniadis EG; Marmor S; Diep GK; Hui JYC; Jensen EH; Tuttle TM
Ann Surg Oncol; 2017 Oct; 24(11):3361-3367. PubMed ID: 28699133
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.
Volpe CM; Driscoll DL; Douglass HO
Ann Surg Oncol; 2000 Mar; 7(2):139-44. PubMed ID: 10761793
[TBL] [Abstract][Full Text] [Related]
14. Should gastric cardia cancers be treated with esophagectomy or total gastrectomy? A comprehensive analysis of 4,996 NSQIP/SEER patients.
Martin JT; Mahan A; Zwischenberger JB; McGrath PC; Tzeng CW
J Am Coll Surg; 2015 Apr; 220(4):510-20. PubMed ID: 25667138
[TBL] [Abstract][Full Text] [Related]
15. Ratio of metastatic to examined lymph nodes is a predictor of mortality in locally advanced gastric cancer treated chemo-radiotherapy.
Unal D; Oguz A; Turak EE; Tasdemir A; Ozturk F; Kurtul N; Eroglu C
Hepatogastroenterology; 2014 Oct; 61(135):2141-8. PubMed ID: 25713921
[TBL] [Abstract][Full Text] [Related]
16. Impact on survival of the number of lymph nodes resected in patients with lymph node-negative gastric cancer.
Chu X; Yang ZF
World J Surg Oncol; 2015 Jun; 13():192. PubMed ID: 26026805
[TBL] [Abstract][Full Text] [Related]
17. Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.
Park SH; Sohn TS; Lee J; Lim DH; Hong ME; Kim KM; Sohn I; Jung SH; Choi MG; Lee JH; Bae JM; Kim S; Kim ST; Park JO; Park YS; Lim HY; Kang WK
J Clin Oncol; 2015 Oct; 33(28):3130-6. PubMed ID: 25559811
[TBL] [Abstract][Full Text] [Related]
18. National Trends in Multimodality Therapy for Locally Advanced Gastric Cancer.
Sada YH; Smaglo BG; Tran Cao HS; Mok H; Musher BL; Massarweh NN
J Surg Res; 2019 May; 237():41-49. PubMed ID: 30694790
[TBL] [Abstract][Full Text] [Related]
19. Impact of Lymph Nodes Examined on Survival in ypN0 Gastric Cancer Patients: a Population-Based Study.
MingHua Z; KeCheng Z; ZhenYu C; Lin C; ChunXi W; ZeLong Y
J Gastrointest Surg; 2021 Apr; 25(4):919-925. PubMed ID: 32318943
[TBL] [Abstract][Full Text] [Related]
20. Role of D2 gastrectomy in gastric cancer with clinical para-aortic lymph node metastasis.
Zheng XH; Zhang W; Yang L; Du CX; Li N; Xing GS; Tian YT; Xie YB
World J Gastroenterol; 2019 May; 25(19):2338-2353. PubMed ID: 31148905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
